The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2 ) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)
Open accessAbstract
SMA is an inherited disease that leads to loss of motor function and ambulation and a reduced life expectancy. We have been working to develop orally administrated, systemically distributed small molecules to increase levels of functional SMN protein. Compound 2 was the first SMN2 splicing modifier tested in clinical trials in healthy volunteers and SMA patients. It was safe and well tolerated and increased SMN protein levels up to 2-fold in patients. Nevertheless, its development was stopped as a precautionary measure because retinal toxicity was observed in cynomolgus monkeys after chronic daily oral dosing (39 weeks) at exposures in excess of those investigated in patients. Herein, we describe the discovery of 1 (risdiplam, RG7916, RO7034067) that focused on thorough pharmacology, DMPK and safety characterization and optimization. This compound is undergoing pivotal clinical trials and is a promising medicine for the treatment of patients in all ages and stages with SMA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bochevarov, A. D., Harder, E., Hughes, T. F., Greenwood, J. R., Braden, D. A., Philipp, D. M., Rinaldo, D., Halls, M. D., Zhang, J., & Friesner, R. A. (2013) · International Journal of Quantum Chemistry · doi:10.1002/qua.24481 · Cited by 1,798
Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C. F., & Krainer, A. R. (2011) · Nature · doi:10.1038/nature10485 · Cited by 741
Sugarman, E. A., Nagan, N., Zhu, H., Akmaev, V. R., Zhou, Z., Rohlfs, E. M., Flynn, K., Hendrickson, B. C., Scholl, T., Sirko-Osadsa, D. A., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.134 · Cited by 661
Schrank, B., Götz, R., Gunnersen, J. M., Ure, J. M., Toyka, K. V., Smith, A. G., & Sendtner, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9920 · Cited by 661
Le, T. T., Pham, L. T., Butchbach, M. E. R., Zhang, H. L., Monani, U. R., Coovert, D. D., Gavrilina, T. O., Xing, L., Bassell, G. J., & Burghes, A. H. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi078 · Cited by 598
Passini, M. A., Bu, J., Richards, A. M., Kinnecom, C., Sardi, S. P., Stanek, L. M., Hua, Y., Rigo, F., Matson, J., Hung, G., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001777 · Cited by 547
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy
Naryshkin, N. A., Weetall, M., Dakka, A., Narasimhan, J., Zhao, X., Feng, Z., Ling, K. K. Y., Karp, G. M., Qi, H., Woll, M. G., et al. (2014) · Science · doi:10.1126/science.1250127 · Cited by 524
Self-citationThe Neurobiology of Childhood Spinal Muscular Atrophy
Crawford, T. O., & Pardo, C. A. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0010 · Cited by 523
SMN2 splice modulators enhance U1–pre-mRNA association and rescue SMA mice
Palacino, J., Swalley, S. E., Song, C., Cheung, A. K., Shu, L., Zhang, X., Van Hoosear, M., Shin, Y., Chin, D. N., Keller, C. G., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1837 · Cited by 432
CLASSIFICATION OF SPINAL MUSCULAR ATROPHIES
Pearn, J. (1980) · The Lancet · doi:10.1016/s0140-6736(80)90847-8 · Cited by 422
Ye, H., Kelly, T. F., Samadani, U., Lim, L., Rubio, S., Overdier, D. G., Roebuck, K. A., & Costa, R. H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1626 · Cited by 359
The SMN complex, an assemblyosome of ribonucleoproteins
Paushkin, S., Gubitz, A. K., Massenet, S., & Dreyfuss, G. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00332-0 · Cited by 351
Self-citationNew and Original p Ka Prediction Method Using Grid Molecular Interaction Fields
Milletti, F., Storchi, L., Sforna, G., & Cruciani, G. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700018y · Cited by 308
The winged-helix transcription factor Trident is expressed in cycling cells
Korver, W., Roose, J., & Clevers, H. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.9.1715 · Cited by 238
Advances in therapy for spinal muscular atrophy: promises and challenges
Groen, E. J. N., Talbot, K., & Gillingwater, T. H. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2018.4 · Cited by 235
Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers
Sivaramakrishnan, M., McCarthy, K. D., Campagne, S., Huber, S., Meier, S., Augustin, A., Heckel, T., Meistermann, H., Hug, M. N., Birrer, P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01559-4 · Cited by 226
Self-citationSpinal muscular atrophy: The role of SMN in axonal mRNA regulation
Fallini, C., Bassell, G. J., & Rossoll, W. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.044 · Cited by 215
Crawford, T. O., Paushkin, S. V., Kobayashi, D. T., Forrest, S. J., Joyce, C. L., Finkel, R. S., Kaufmann, P., Swoboda, K. J., Tiziano, D., Lomastro, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033572 · Cited by 158
Self-citationMacGregor, J. T., Frötschl, R., White, P. A., Crump, K. S., Eastmond, D. A., Fukushima, S., Guérard, M., Hayashi, M., Soeteman‐Hernández, L. G., Johnson, G. E., et al. (2014) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2014.10.008 · Cited by 130
Ratni, H., Karp, G. M., Weetall, M. L., Naryshkin, N. A., Paushkin, S. V., Chen, K. S., McCarthy, K. D., Qi, H., Turpoff, A., Woll, M. G., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00459 · Cited by 119
Self-citationOsborne, M. A., Gomez, D., Feng, Z., McEwen, C., Beltrán, J., Cirillo, K., El‐Khodor, B. F., Lin, M.-Y., Li, Y., Knowlton, W., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds285 · Cited by 63
Self-citationTherapeutic approaches for spinal muscular atrophy (SMA)
Scoto, M., Finkel, R. S., Mercuri, E. M., & Muntoni, F. (2017) · Gene Therapy · doi:10.1038/gt.2017.45 · Cited by 61
Pathological impact of SMN2 mis‐splicing in adult SMA mice
Sahashi, K., Ling, K., Hua, Y., Wilkinson, J. E., Nomakuchi, T. T., Rigo, F., Hung, G., Xu, D. S., Jiang, Y., Lin, R. Z., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302567 · Cited by 55
Self-citationPoirier, A., Cascais, A., Bader, U., Portmann, R., Brun, M.-E., Walter, I., Hillebrecht, A., Ullah, M., & Funk, C. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.057943 · Cited by 48
Self-citationPinard, E., Green, L., Reutlinger, M., Weetall, M. L., Naryshkin, N. A., Baird, J. D., Chen, K. S., Paushkin, S. V., Metzger, F., & Ratni, H. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00406 · Cited by 35
Self-citationInvestigational therapies for the treatment of spinal muscular atrophy
Kaczmarek, A., Schneider, S. M., Wirth, B., & Rießland, M. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1038341 · Cited by 27
Manananggal - a novel viewer for alternative splicing events
Barann, M., Zimmer, R., & Birzele, F. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1548-5 · Cited by 9
Cited by
Malard, F., Wolter, A. C., Marquevielle, J., Morvan, E., Ecoutin, A., Rüdisser, S. H., Allain, F. H. T., & Campagne, S. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae201 · Cited by 1,273
Targeting RNA structures with small molecules
Childs-Disney, J. L., Yang, X., Gibaut, Q. M. R., Tong, Y., Batey, R. T., & Disney, M. D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00521-4 · Cited by 587
Risdiplam in Type 1 Spinal Muscular Atrophy
Baranello, G., Darras, B. T., Day, J. W., Deconinck, N., Klein, A., Masson, R., Mercuri, E., Rose, K., El-Khairi, M., Gerber, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2009965 · Cited by 436
Self-citationRNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
Yu, A.-M., Choi, Y. H., & Tu, M.-J. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019554 · Cited by 395
Phenotypic drug discovery: recent successes, lessons learned and new directions
Vincent, F., Nueda, A., Lee, J., Schenone, M., Prunotto, M., & Mercola, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00472-w · Cited by 348
Metadata
- Authors
- Ratni, H., Ebeling, M., Baird, J., Bendels, S., Bylund, J., Chen, K. S., Denk, N., Feng, Z., Green, L., Guerard, M., Jablonski, P., Jacobsen, B., Khwaja, O., Kletzl, H., Ko, C.-P., Kustermann, S., Marquet, A., Metzger, F., Mueller, B., Naryshkin, N. A., Paushkin, S. V., Pinard, E., Poirier, A., Reutlinger, M., Weetall, M., Zeller, A., Zhao, X., & Mueller, L.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-07-25
- Volume
- 61
- Issue
- 15
- Pages
- 6501-6517
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2883929619
- Cited by
- 537
- References
- 27
- Type
- other
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.